Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Completed 5Terminated 2Withdrawn 1Unknown 1Recruiting 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Tumor-Agnostic 2

Conditions

Neoplasms 2Prostatic Neoplasms 1Neuroectodermal Tumors, Primitive 1Neoplasm Metastasis 1Medulloblastoma 1Glioma 1Carcinoma 1Breast Neoplasms, Male 1Breast Neoplasms 1

Interventions

Gemcitabine 34pembrolizumab 27Paclitaxel 21Cyclophosphamide 21Docetaxel 20Carboplatin 20Irinotecan 19Capecitabine 19Fluorouracil 17Bevacizumab 15Dexamethasone 14fludarabine 13Oxaliplatin 13Leucovorin 13Blood Specimen Collection 13Everolimus 12Cetuximab 12Ipilimumab 11Erlotinib Hydrochloride 11Rituximab 10Pemetrexed 10Cisplatin 10venetoclax 9Temozolomide 9Sunitinib 9Nivolumab 9Trastuzumab 8Interleukin-2 8aldesleukin 7Epoetin Alfa 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Terminated × Neoplasms × Vaccines × Clear all
NCT06175221 2025-09-15

Autologous TLPO Vaccine Basket

Elios Therapeutics, LLC

Phase 2 Terminated
63 enrolled
Tumor-Agnostic

Neoplasm Metastasis, Neoplasms

NCT00684294 2020-03-02

Auto TAG

Mary Crowley Medical Research Center

Phase 1 Terminated
46 enrolled
Tumor-Agnostic

Carcinoma, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡